KHSRP knockdown inhibits papillary renal cell carcinoma progression and sensitizes to gemcitabine

• 主要な著者: Wei Song (著者), Heng Zhang (著者), Yi Lu (著者), Houliang Zhang (著者), Jinliang Ni (著者), Lan Chang (著者), Yongzhe Gu (著者), Guangchun Wang (著者), Tianyuan Xu (著者), Zonglin Wu (著者), Keyi Wang (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2024-10-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Patients diagnosed with papillary renal cell carcinoma (pRCC) exhibit a high rate of clinical metastasis; however, the underlying molecular mechanism is unclear. In this study, KH-type splicing regulatory protein (KHSRP) participated in pRCC progression and was associated with metastasis. It was pos...